Impact of heart transplantation on survival in patients on venoarterial extracorporeal membrane oxygenation at listing in France

Transplantation

Volumn 100, Issue 9, 2016, Pages 1979-1987

  Jasseron, Carine ^a   Lebreton, Guillaume ^b   Cantrelle, Christelle ^a   Legeai, Camille ^a   Leprince, Pascal ^b   Flecher, Erwan ^c   Sirinelli, Agnes ^d   Bastien, Olivier ^a   Dorent, Richard ^a  

^a Agence de la Biomedecine   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; CONFIDENCE INTERVAL; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION; DIALYSIS; DISEASE REGISTRY; EXTRACORPOREAL OXYGENATION; FEMALE; FRANCE; HAZARD RATIO; HEART TRANSPLANTATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK REDUCTION; SURVIVAL RATE; TIME; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VENOARTERIAL EXTRACORPOREAL OXYGENATION; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; HOSPITAL ADMISSION; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

CHI-SQUARE DISTRIBUTION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84974782337     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001265     Document Type: Article

References (24)

1. Agence Biomedcine. The Medical and Scientific Report of the Biomedical Agency. http://www.agence-biomedecine.fr/annexes/bilan2013/donnees/organes/03-coeur/synthese.htm. Published 2013. Accessed 2016.
2. Shekar K, Mullany DV, Thomson B, et al. Extracorporeal life support devices and strategies for management of acute cardiorespiratory failure in adult patients: A comprehensive review. Crit Care. 2014;18:219.
3. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012;33:1787-1847.
4. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;128:1810-1852.
5. Peura JL, Colvin-Adams M, Francis GS, et al. Recommendations for the use ofmechanical circulatory support: device strategies and patient selection: A scientific statement from the American Heart Association. Circulation. 2012;126:2648-2667.
6. Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013; 32:157-187.
7. Banner NR, Bonser RS, Clark AL, et al. UK guidelines for referral and assessment of adults for heart transplantation. Heart. 2011;97:1520-1527.
8. Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: Thirty-first official adult heart transplant report-2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:996-1008.
9. Smedira NG, Hoercher KJ, Yoon DY, et al. Bridge to transplant experience: factors influencing survival to and after cardiac transplant. J Thorac Cardiovasc Surg. 2010;139:1295-1305.
10. Wever-Pinzon O, Drakos SG, Kfoury AG, et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support. Is reappraisal of the current United Network for Organ Sharing thoracic organ allocation policy justified? Circulation. 2013;127:452-462.
11. Meyer DM, Rogers JG, Edwards LB, et al. The future direction of the adult heart allocation system in the United States. Am J Transplant. 2015;15:44-54.
12. Weiss ES, Allen JG, Arnaoutakis GJ, et al. Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). Ann Thorac Surg. 2011;92:914-921.
13. Karamlou T, Gelow J, Diggs BS, et al. Mechanical circulatory support pathways that maximize post-heart transplant survival. Ann Thorac Surg. 2013;95:480-485.
14. Barge-Caballero E, Almenar-Bonet L, Villa-Arranz A, et al. Impact of shortterm mechanical circulatory support with extracorporeal devices on postoperative outcomes after emergency heart transplantation: data from a multi-institutional Spanish cohort. Int J Cardiol. 2014;176:86-93.
15. Barbaro RP, Odetola FO, Kidwell KM, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality- Analysis of the Extracorporeal Life Support Organization Registry. Am J Respir Crit Care Med. 2015;48(5):785-791.
16. Barth E, Durand M, Heylbroeck C, et al. Extracorporeal life support as a bridge to high-urgency heart transplantation. Clin Transplant. 2012;26: 484-488.
17. Cho YH, Yang JH, Sung K, et al. Extracorporeal life support as a bridge to heart transplantation: importance of organ failure in recipient selection. ASAIO J. 2015;61:139-143.
18. Pagani FD, Aaronson KD, Swaniker F, et al. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg. 2001;71:S77-S81.
19. Lebreton G, Pozzi M, Mastroianni C, et al. Leprince. Extracorporeal life support as a bridge to bridge: A strategy to optimize ventricular assist device results. Eur J Cardiothorac Surg. 2015;191:894-901.
20. Pagani FD, Lynch W, Swaniker F, et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant. A strategy to optimize survival and resource utilization. Circulation. 1999;100:II206-II210.
21. Pagani FD, Aaronson KD, Dyke DB, et al. Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy. Ann Thorac Surg. 2000;70:1977-1984.
22. Hoefer D, Ruttmann E, Poelzl G, et al. Outcome evaluation of the bridge to bridge concept in patients with cardiogenic shock. Ann Thorac Surg. 2006;82:28-33.
23. Boulate D, Luyt CE, Pozzi M, et al. Acute lung injury after mechanical circulatory support implantation in patients on extracorporeal life support: An unrecognized problem. Eur J Cardiothorac Surg. 2013;44:544-549.
24. Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: A 10, 000-patients database. J Heart Lung Transplant. 2014;33:555-564.